Evidence map›Paper›PMID 27060940›Full record

ArticleJournal of Alzheimer's disease : JAD2016

A Late Life Risk Index for Severe Cognitive Impairment in Mexico.

Brian Downer, Sreenivas P Veeranki, Rebeca Wong

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian DownerUniversity of Texas Medical Branch, Division of Rehabilitation Sciences, Galveston, TX, USA.
Sreenivas P VeerankiUniversity of Texas Medical Branch, Preventive Medicine and Community Health, Galveston, TX, USA.
Rebeca WongUniversity of Texas Medical Branch, Preventive Medicine and Community Health, Galveston, TX, USA.

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
The Mexican Health and Aging Study - IIR01AG018016 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Rebeca Wong · 1999 to 2026
$22.6M
HEALTH OF OLDER MINORITIEST32AG000270 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Brian Gregory Downer, NEIL MEHTA · 1999 to 2026
$5.2M
Longitudinal Impact of CNS Polypharmacy on Geriatric SyndromesR01AG027017 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HANLON, JOSEPH T · 2006 to 2012
$801k
Longitudinal Impact of Antihypertensive Polypharmacy on Geriatric SyndromesR56AG027017 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HANLON, JOSEPH T · 2010 to 2010
$242k
NIA NIH HHS P30 AG024832NIA NIH HHS R01 AG018016NIA NIH HHS R01 AG027017NIA NIH HHS R56 AG027017NIA NIH HHS T32 AG000270
6 · The paper itself

Abstract

backgroundSeveral dementia risk indices have been developed for older adults in high-income countries. However, no index has been developed for populations in low- or middle-income countries.

objectiveTo create a risk index for predicting severe cognitive impairment among adults aged ≥60 in Mexico and to compare the accuracy of this index to the Dementia Screening Indicator (DSI).

methodsThis study included 3,002 participants from the Mexican Health and Aging Study (MHAS) interviewed in 2001 and 2012. The MHAS risk index included sociodemographic, health, and functional characteristics collected in 2001. A point value based on the beta coefficients from a multivariable logistic regression model was assigned to each risk factor and the total score was calculated.

resultsThe MHAS risk index (AUC = 0.74 95% CI = 0.70-0.77) and DSI (AUC = 0.72 95% CI = 0.69-0.77) had similar accuracy for discriminating between participants who developed severe cognitive impairment from those who did not. A score of ≥16 on the MHAS risk index had a sensitivity of 0.69 (95% CI = 0.64-0.70) and specificity of 0.67 (95% CI = 0.66-0.69). A score of ≥23 on the DSI had a sensitivity of 0.56 (95% CI = 0.50-0.63) and specificity of 0.78 (95% CI = 0.76-0.79). DISCUSSION: The MHAS risk index and DSI have moderate accuracy for predicting severe cognitive impairment among older adults in Mexico. This provides evidence that existing dementia risk indices may be applicable in low- and middle-income countries such as Mexico. Future research should seek to identify additional risk factors that can improve the accuracy of the MHAS risk index.

Indexed as

AgedAge FactorsCognitive DysfunctionFemaleHumansLife StyleLogistic ModelsLongitudinal StudiesMaleMexicoMiddle AgedMultivariate AnalysisRisk FactorsSocial BehaviorSocioeconomic FactorsAgingdementiadiagnosisMexico

Identifiers

PMID27060940
PMCPMC4852305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.